Align technology announces $100 million open market repurchase

Tempe, ariz.--(business wire)--align technology, inc. (“align”) (nasdaq: algn) a leading global medical device company that designs, manufactures, and sells the invisalign® system of clear aligners, itero™ intraoral scanners, and exocad™ cad/cam software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $100 million of align's common stock through open market repurchases under align's $1.0 billion stock repurchase program that was approved by.
ALGN Ratings Summary
ALGN Quant Ranking